GT Biopharma, Inc. — Director's Dealing 2003

Dec 9, 2003

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OXIS INTERNATIONAL INC (OTTCBB)
CIK: 0000109657
Period of Report: 2003-12-08

Reporting Person: WOLF THOMAS M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2003-12-04	Stock Option (right to buy)	$0.57	A	12280	Disposed	2013-12-03	common stock (12280)	Direct